ETF Research

GDOC: GOLDMAN SACHS FUTURE HEALTH CARE EQUITY ETF

Generated from StockValueFinder data · Updated Oct 11, 2026 11:28 PM
Educational content only. This is not financial advice and is not a recommendation to buy, sell, or hold any ETF.

What this ETF is trying to do

The Goldman Sachs Future Health Care Equity ETF (GDOC) invests in companies within the healthcare sector. Based on its top holdings, it focuses on large pharmaceutical and medical companies. As of October 7, 2026, its top holdings include Eli Lilly and Co (12.28%), Johnson & Johnson (8.33%), and Merck & Co Inc (7.36%). This is a partial list of its 41 total holdings.

What the numbers show

The current price of the ETF is $36.76. To understand how the price has changed, we can look at the price return (which tracks only the share price) and the total return (which includes distributions).

• Year-to-Date: The price return is 3.55%, and the total return is also 3.55%.

• One Year: The price return is 10.23%, while the total return is 10.58%.

• Three Year: The price return is 22.86%, and the total return is 23.94%.

For a simple example, if you had invested $10,000 exactly one year ago at the estimated price of $33.35, the price-only increase would have grown that investment to approximately $11,023.

Income and distribution explanation

This ETF pays out cash distributions, but they are irregular and less frequent. In the last 12 months, there was only one payout. The distribution yield is 0.31%.

It is important for beginners to know that a distribution yield is not the same as a total return. While distributions provide cash income, they do not guarantee that the original investment value will stay the same. In this case, the yield is quite low.

NAV erosion explanation

"NAV erosion" happens when the net asset value of a fund declines over time, which can eat away at an investor's principal. StockValueFinder uses an erosion-risk score to measure this.

GDOC has an erosion score of 100, and the erosion label states "No price erosion detected." The erosion severity is rated as "good," and there is no severe erosion-risk flag for this ETF.

Pros

• Positive Returns: The ETF has shown positive price and total returns over the last one and three years.

• Low Erosion Risk: The data indicates no detected price erosion.

• Diversified Healthcare Exposure: It holds a variety of major healthcare companies.

Cons

• Low Income: The distribution yield is very low (0.31%).

• Irregular Payouts: Distributions do not happen on a steady, predictable schedule.

Beginner takeaway

GDOC is a healthcare-focused ETF that has seen its share price grow over the last three years. While it provides a small amount of cash income, it is not designed for investors seeking high regular payouts. Its primary growth has come from the increase in share price rather than distributions.

Top Holdings

Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.

41 holdings available
# Holding Ticker Weight
1 ELI LILLY AND CO LLY 12.28%
2 JOHNSON & JOHNSON JNJ 8.33%
3 MERCK & CO INC MRK 7.36%
4 UNITEDHEALTH GROUP INC UNH 5.49%
5 VERTEX PHARMACEUTICALS INC VRTX 4.06%
6 GUARDANT HEALTH INC GH 4.04%
7 AGILENT TECHNOLOGIES INC A 3.97%
8 THERMO FISHER SCIENTIFIC INC TMO 3.86%
9 DEXCOM INC DXCM 3.69%
10 ARGENX SE ADR ARGX 3.54%
Show all 41 holdings
1. ELI LILLY AND CO LLY 12.28%
2. JOHNSON & JOHNSON JNJ 8.33%
3. MERCK & CO INC MRK 7.36%
4. UNITEDHEALTH GROUP INC UNH 5.49%
5. VERTEX PHARMACEUTICALS INC VRTX 4.06%
6. GUARDANT HEALTH INC GH 4.04%
7. AGILENT TECHNOLOGIES INC A 3.97%
8. THERMO FISHER SCIENTIFIC INC TMO 3.86%
9. DEXCOM INC DXCM 3.69%
10. ARGENX SE ADR ARGX 3.54%
11. EDWARDS LIFESCIENCES CORP EW 3.33%
12. INTUITIVE SURGICAL INC ISRG 3.19%
13. LONZA GROUP LTD n/a 2.73%
14. ROIVANT SCIENCES LTD ORDINARY SHARES ROIV 2.64%
15. CENCORA INC COR 2.50%
16. REPLIGEN CORP RGEN 2.19%
17. ASTRAZENECA PLC AZN 2.04%
18. NATERA INC NTRA 2.03%
19. METTLER-TOLEDO INTERNATIONAL INC MTD 1.85%
20. 10X GENOMICS INC ORDINARY SHARES CLASS A TXG 1.73%
21. INSMED INC INSM 1.68%
22. ROYALTY PHARMA PLC CLASS A RPRX 1.67%
23. CYTOKINETICS INC CYTK 1.47%
24. BOSTON SCIENTIFIC CORP BSX 1.40%
25. QUEST DIAGNOSTICS INC DGX 1.35%
26. GALDERMA GROUP AG REGISTERED SHARES n/a 1.34%
27. GOLDMAN SACHS FS TREASURY OBLIGS INSTL FTOXX 1.13%
28. HOYA CORP n/a 1.08%
29. VEEVA SYSTEMS INC CLASS A VEEV 1.05%
30. MADRIGAL PHARMACEUTICALS INC MDGL 0.97%
31. BRIDGEBIO PHARMA INC BBIO 0.82%
32. DIANTHUS THERAPEUTICS INC DNTH 0.80%
33. RHYTHM PHARMACEUTICALS INC RYTM 0.66%
34. SARTORIUS STEDIM BIOTECH SA n/a 0.58%
35. DEFINIUM THERAPEUTICS INC ORDINARY SHARES DFTX 0.52%
36. PRAXIS PRECISION MEDICINES INC ORDINARY SHARES PRAX 0.52%
37. SPYRE THERAPEUTICS INC SYRE 0.52%
38. ALKERMES PLC ALKS 0.49%
39. KYMERA THERAPEUTICS INC ORDINARY SHARES KYMR 0.40%
40. KARDIGAN INC KARD 0.36%
41. CG ONCOLOGY INC CGON 0.35%
Holdings data last updated Oct 7, 2026 6:35 AM .
Scroll to Top